Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash runway through 2027.
Ethereum Beats XRP, Bitcoin In Wallet Growth, But Here's Why That's (Probably) Irrelevant On-chain data shows Ethereum (CRYPTO: ETH) remains the blockchain with the fastest wallet growth, followed by XRP
Nike Posts Q2 Earnings Beat, Expects Tariff Headwinds From China Nike "is still struggling to gain traction and continues to take longer," Needham analyst Tom Nikic wrote in a note.
Accenture's AI Momentum Impresses Analysts Despite Early-Stage Rollouts Accenture's Q1 earnings call reveals steady increase in client demand for AI projects, but acknowledges early stages and limited scale.
What's Going On With Darden Restaurants Stock Today? Darden slipped after a slight earnings-per-share miss, even as analysts kept upbeat targets and pointed to steady demand signals.
Sony Goes All-In On Snoopy, Scoops Up Control Of Peanuts Empire Sony's entertainment units agreed to buy WildBrain's stake, lifting Sony's indirect Peanuts ownership to a controlling level, pending approvals.
Markets Bounce, CPI Cools, And Nike Earnings Stumble Stocks rallied yesterday as softer inflation data hit the tape, but Nike's latest report raises fresh questions about global demand.
Vuzix Smart Vision Is Going From The Lab To The Battlefield Vuzix expands in defense tech through extended collaboration with Collins Aerospace and RTX, progressing towards operational readiness.
FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold Cassava Sciences confirms an FDA clinical hold on its simufilam epilepsy trial, delaying plans and requiring more data despite strong cash reserves.
CarMax Bets On Lower Prices To Jumpstart Sales After 47% Profit Drop CarMax plans to lower prices and increase ad spend after reporting in-line Q3 results. Analyst reduced PT to $36, maintains Equal-Weight.
XRP Below $2 Is An Opportunity, But It Better Not Follow This Cardano Pattern, Trader Warns XRP (CRYPTO: XRP) slipping below the $2 mark signals near-term weakness, even as technical indicators begin to hint at a
Birkenstock Posts Q4 Beat, Offset By Ongoing FX, Tariff Pressures Birkenstock Holding reported strong Q4 results, but forex and tariffs dampened margins. What does a Guggenheim Securities analyst think?
Trump‑Venezuela Conflict Odds Top 50% In Betting Markets — Time To Buy Cheap Oil? Betting markets now put the odds of a U.S. military move in Venezuela above 50% by early 2026. Oil prices remain near multi-year lows.
What's Going On With CoreWeave Stock Friday? CoreWeave shares are trading higher Thursday after the company announced it joined the Department of Energy's Genesis Mission.
Bitcoin Pops To $88,000 But Don't Get Too Excited: On-Chain Data Says 'Dead-Cat Bounce' Bitcoin (CRYPTO: BTC) remains range-bound below $90,000 as on-chain data points to a growing supply–demand mismatch rather than a
What's Going On With Oracle Stock Today? Shares of Oracle Corporation are trading higher Friday after reports confirmed the technology company will be one of TikTok's new owners.
What's Going On With Safe & Green Holdings Stock? Shares of Safe & Green Holdings Corp. (
NASDAQ: SGBX ) are on watch Friday after the construction engineering company acquired Giant Holdings.
BioMarin Boosts Rare Disease Portfolio With Amicus Buyout, Stocks Rally BioMarin acquires Amicus for $4.8B, expanding its rare disease portfolio with Fabry and Pompe therapies, in a deal expected to close Q2 2026.
Congressman Can't Stop Buying Magnificent 7 Stocks: These Are His Latest Picks A member of Congress who has poured millions into six of the seven Magnificent Seven stocks in 2025 appears to favor one above the rest.
Wall Street Got Smoked By These 20 Stock Markets In 2025 Global equity markets crushed Wall Street in 2025 as South Korea, Peru and Europe posted massive gains, far outpacing the S&P 500.
Why Is Autozi Stock Gaining Friday? Autozi shares jumped after the company said CDIB confirmed a major equity investment to fund digital expansion and broader growth plans.
GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperform and highlight 2026 clinical milestones.
Paychex Scales Fast After Paycor Acquisition, Lifts Profit Outlook Paychex, Inc. (
NASDAQ: PAYX ) reported strong Q2 results with 18% increase in revenue. Adjusted EPS beat estimates, while sales missed.
Lamb Weston Shares Sink As Pricing Pressure Weighs Lamb Weston shares fall sharply despite a Q2 earnings beat, as pricing pressure, lower margins and EBITDA decline overshadow strong volume growth and market share gains.
ConAgra Flags Rising Costs From Tariffs, Keeps Cautious Outlook ConAgra (CAG) stock falls after mixed quarter, with profit beat and revenue miss. Full-year outlook reaffirmed amid tariff pressure.
